HRP20140435T1 - Dispiro-1,2,4-trioksolanski antimalarici - Google Patents
Dispiro-1,2,4-trioksolanski antimalarici Download PDFInfo
- Publication number
- HRP20140435T1 HRP20140435T1 HRP20140435AT HRP20140435T HRP20140435T1 HR P20140435 T1 HRP20140435 T1 HR P20140435T1 HR P20140435A T HRP20140435A T HR P20140435AT HR P20140435 T HRP20140435 T HR P20140435T HR P20140435 T1 HRP20140435 T1 HR P20140435T1
- Authority
- HR
- Croatia
- Prior art keywords
- trioxolane
- dispiro
- cis
- trioxaspiro
- adamantane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
- C07D323/02—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/930,606 US8067620B2 (en) | 2005-05-04 | 2007-10-31 | Dispiro 1,2,4-trioxolane antimalarials |
| PCT/US2008/081579 WO2009058859A2 (en) | 2007-10-31 | 2008-10-29 | Dispiro 1,2,4-trioxolane antimalarials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20140435T1 true HRP20140435T1 (hr) | 2014-06-20 |
Family
ID=40228026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20140435AT HRP20140435T1 (hr) | 2007-10-31 | 2008-10-29 | Dispiro-1,2,4-trioksolanski antimalarici |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8067620B2 (enExample) |
| EP (1) | EP2203457B1 (enExample) |
| JP (1) | JP5559057B2 (enExample) |
| KR (1) | KR101588468B1 (enExample) |
| CN (1) | CN101842377B (enExample) |
| AU (1) | AU2008318819C1 (enExample) |
| BR (1) | BRPI0818121B8 (enExample) |
| CA (1) | CA2702256C (enExample) |
| CY (1) | CY1115148T1 (enExample) |
| DK (1) | DK2203457T3 (enExample) |
| ES (1) | ES2466319T3 (enExample) |
| HR (1) | HRP20140435T1 (enExample) |
| MX (1) | MX2010004601A (enExample) |
| PL (1) | PL2203457T3 (enExample) |
| PT (1) | PT2203457E (enExample) |
| RU (1) | RU2493159C2 (enExample) |
| SI (1) | SI2203457T1 (enExample) |
| UA (1) | UA99742C2 (enExample) |
| WO (1) | WO2009058859A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8067620B2 (en) * | 2005-05-04 | 2011-11-29 | Medicines For Malaria Venture Mmv | Dispiro 1,2,4-trioxolane antimalarials |
| CN103429607B (zh) | 2011-01-31 | 2016-02-17 | 百时美施贵宝公司 | 具有hiv成熟抑制活性的c-17和c-3经修饰的三萜系化合物 |
| CA2874295A1 (en) * | 2012-06-13 | 2013-12-19 | Medizinische Universitat Wien | Amidophenoxypropanolamines |
| US10287312B2 (en) | 2014-02-14 | 2019-05-14 | The Regents Of The University Of California | Cyclic peroxides as prodrugs for selective delivery of agents |
| EP3526214A1 (en) | 2016-10-13 | 2019-08-21 | MMV Medicines for Malaria Venture | New anti-malarial agent |
| EP3309156A1 (en) | 2016-10-13 | 2018-04-18 | MMV Medicines for Malaria Venture | New anti-malarial agents |
| US11246854B2 (en) | 2017-05-16 | 2022-02-15 | The Johns Hopkins University | Ozonides for treating or preventing virus infections |
| US11072594B2 (en) | 2017-06-27 | 2021-07-27 | The Regents Of The University Of California | Trioxolane agents |
| CN110878069A (zh) * | 2019-12-09 | 2020-03-13 | 南京杰运医药科技有限公司 | 一种4-吗琳基-2-乙基哌嗪的制备方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3621062A (en) * | 1966-10-25 | 1971-11-16 | Sterling Drug Inc | 2-(8-cyclohexyloctanoyl or 7-cyclohexylheptanoyl)-1-naphthol |
| US3673222A (en) * | 1969-11-26 | 1972-06-27 | Sydney Archer | 2-(8-cyclohexyloctyl or 7-cyclohexylheptyl)-1,4-naphthoquinone and process for preparation and use thereof |
| US3682991A (en) * | 1970-10-19 | 1972-08-08 | Sterling Drug Inc | 3,3,5-trimethylcyclohexyl-alkyl-carboxylic acids |
| US4978678A (en) * | 1986-11-20 | 1990-12-18 | Hoechst-Roussel Pharmaceuticals Inc. | 12-halogenated forskolin derivatives |
| US4916204A (en) | 1987-07-31 | 1990-04-10 | Massachusetts Institute Of Technology | Pure polyanhydride from dicarboxylic acid and coupling agent |
| US4816478A (en) * | 1987-08-24 | 1989-03-28 | Thornfeldt Carl R | Treatment of acquired immunodeficiency syndrome |
| US5053342A (en) * | 1987-12-24 | 1991-10-01 | Litmus Concepts, Inc. | Fecal occult blood test reagents |
| US5559145A (en) * | 1988-06-01 | 1996-09-24 | Oxaco S.A. | 1,2,4-trioxane derivatives |
| US5270344A (en) * | 1988-06-24 | 1993-12-14 | Stephen Herman | Method of treating a systemic disorder using trioxolane and diperoxide compounds |
| JP2867529B2 (ja) * | 1990-01-22 | 1999-03-08 | 三菱電機株式会社 | 投写型表示装置 |
| US5216175A (en) * | 1990-03-23 | 1993-06-01 | Sri International | Antimalarial analogs of artemisinin |
| US5219880A (en) * | 1991-03-29 | 1993-06-15 | Dermatologic Research Corporation | Treatment of viral tumors and hemorrhoids with artemisinin and derivatives |
| US5510356A (en) * | 1991-10-03 | 1996-04-23 | University Of Nebraska Board Of Regents | Bisquinolines and processes for their production and use to treat malaria |
| US5171676A (en) * | 1991-10-31 | 1992-12-15 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of introducing hydroxyl groups into artemisinin and its derivatives |
| US5430148A (en) * | 1992-03-31 | 1995-07-04 | Agouron Pharmaceuticals, Inc. | Antiproliferative quinazolines |
| ATE152630T1 (de) * | 1992-07-28 | 1997-05-15 | Procter & Gamble | Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält |
| US5721209A (en) * | 1995-02-03 | 1998-02-24 | The Regents Of The University Of California | Iron chelator and inhibitor of iron-mediated oxidant injury |
| US5780675A (en) * | 1995-04-28 | 1998-07-14 | The University Of New Mexico | Deoxygossylic compounds |
| US5578637A (en) * | 1995-05-03 | 1996-11-26 | University Of Washington | Methods of inhibition or killing cancer cells using an endoperoxide |
| US5817692A (en) * | 1995-11-22 | 1998-10-06 | The Johns Hopkins University | Endoperoxides useful as antiparasitic agents |
| US5672624A (en) * | 1995-11-22 | 1997-09-30 | The Johns Hopkins University | Endoperoxides useful as antiparasitic agents |
| US5932591A (en) * | 1996-12-02 | 1999-08-03 | Johns Hopkins University | C3 substituted trioxanes useful as antiparasitic drugs |
| US6486199B1 (en) * | 2001-06-21 | 2002-11-26 | Medicines For Malaria Venture Mmv International Centre Cointrin | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| US6906205B2 (en) * | 2002-06-21 | 2005-06-14 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| US6825230B2 (en) * | 2002-06-21 | 2004-11-30 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trixolane antimalarials |
| US7371778B2 (en) * | 2002-06-21 | 2008-05-13 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| US20080125441A1 (en) * | 2002-06-21 | 2008-05-29 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| US8067620B2 (en) | 2005-05-04 | 2011-11-29 | Medicines For Malaria Venture Mmv | Dispiro 1,2,4-trioxolane antimalarials |
| WO2006123314A2 (en) * | 2005-05-18 | 2006-11-23 | Ranbaxy Laboratories Limited | Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials |
-
2007
- 2007-10-31 US US11/930,606 patent/US8067620B2/en active Active
-
2008
- 2008-10-29 ES ES08845311.3T patent/ES2466319T3/es active Active
- 2008-10-29 MX MX2010004601A patent/MX2010004601A/es active IP Right Grant
- 2008-10-29 WO PCT/US2008/081579 patent/WO2009058859A2/en not_active Ceased
- 2008-10-29 CA CA2702256A patent/CA2702256C/en active Active
- 2008-10-29 RU RU2010121919/04A patent/RU2493159C2/ru active
- 2008-10-29 KR KR1020107012029A patent/KR101588468B1/ko not_active Expired - Fee Related
- 2008-10-29 PT PT88453113T patent/PT2203457E/pt unknown
- 2008-10-29 DK DK08845311.3T patent/DK2203457T3/da active
- 2008-10-29 JP JP2010531331A patent/JP5559057B2/ja active Active
- 2008-10-29 BR BRPI0818121A patent/BRPI0818121B8/pt active IP Right Grant
- 2008-10-29 AU AU2008318819A patent/AU2008318819C1/en not_active Ceased
- 2008-10-29 PL PL08845311T patent/PL2203457T3/pl unknown
- 2008-10-29 HR HRP20140435AT patent/HRP20140435T1/hr unknown
- 2008-10-29 CN CN200880114154.6A patent/CN101842377B/zh active Active
- 2008-10-29 UA UAA201005157A patent/UA99742C2/ru unknown
- 2008-10-29 SI SI200831204T patent/SI2203457T1/sl unknown
- 2008-10-29 EP EP08845311.3A patent/EP2203457B1/en active Active
-
2014
- 2014-05-16 CY CY20141100349T patent/CY1115148T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011502131A (ja) | 2011-01-20 |
| UA99742C2 (en) | 2012-09-25 |
| PL2203457T3 (pl) | 2014-08-29 |
| MX2010004601A (es) | 2010-05-27 |
| CA2702256C (en) | 2017-09-26 |
| WO2009058859A2 (en) | 2009-05-07 |
| RU2010121919A (ru) | 2011-12-10 |
| DK2203457T3 (da) | 2014-05-12 |
| BRPI0818121A2 (pt) | 2015-11-17 |
| AU2008318819A1 (en) | 2009-05-07 |
| AU2008318819B2 (en) | 2013-11-21 |
| US20080125411A1 (en) | 2008-05-29 |
| KR101588468B1 (ko) | 2016-01-25 |
| HK1147092A1 (en) | 2011-07-29 |
| JP5559057B2 (ja) | 2014-07-23 |
| CY1115148T1 (el) | 2016-12-14 |
| KR20100087199A (ko) | 2010-08-03 |
| CN101842377B (zh) | 2015-07-01 |
| ES2466319T3 (es) | 2014-06-17 |
| RU2493159C2 (ru) | 2013-09-20 |
| BRPI0818121B8 (pt) | 2021-05-25 |
| SI2203457T1 (sl) | 2014-06-30 |
| AU2008318819C1 (en) | 2014-04-24 |
| BRPI0818121B1 (pt) | 2020-12-08 |
| EP2203457A2 (en) | 2010-07-07 |
| PT2203457E (pt) | 2014-06-06 |
| WO2009058859A3 (en) | 2009-06-18 |
| CA2702256A1 (en) | 2009-05-07 |
| CN101842377A (zh) | 2010-09-22 |
| EP2203457B1 (en) | 2014-03-05 |
| US8067620B2 (en) | 2011-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20140435T1 (hr) | Dispiro-1,2,4-trioksolanski antimalarici | |
| CA3187588A1 (en) | Transdermal pharmaceutical formulations of cannabinoids | |
| AU2020361741B2 (en) | Transdermal compositions comprising cannabidiol (CBD) for use in the treatment of seizure disorders | |
| HRP20090459T1 (hr) | Aminofenil derivati kao novi inhibitori histonskih deacetilaza | |
| UY30107A1 (es) | Nuevos derivados de pirimidina, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones | |
| JP2011502131A5 (enExample) | ||
| AR045161A1 (es) | Derivados de quinazolina | |
| UY31406A1 (es) | "producto de dispersion solida que contiene un compuesto a base de n-aril urea". | |
| UY39032A (es) | Compuestos heterocíclicos como agentes antivirales | |
| HRP20161114T1 (hr) | Sastavi inhibitora kinaze i njihova uporaba za liječenje raka i drugih bolesti povezanih s kinazama | |
| ECSP099767A (es) | Derivados de n' - (fenil) -n- (morfolin-4-il-piridin-2-il) -pirimidina-2, 4-diamina como inhibidores de quinasas ephb4 para el tratamiento de afecciones proliferativas | |
| US20230310440A1 (en) | Respiratory stimulant nasal formulations | |
| MA38854B1 (fr) | Dérivés amides utilisés en tant qu'antagonistes des récepteurs de l'acide lysophosphatidique | |
| FI3911304T3 (fi) | Fosfodiesteraasin estäjiä sisältäviä muutettuja tablettiformulaatioita | |
| ME02020B (me) | Anti-malarijski agensi kao inhibitori dihidroorotat dehidrogenaze | |
| AR064543A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales | |
| US20250114370A1 (en) | Methods and compositions for treating drug overdose | |
| AR047469A1 (es) | Conservantes antimicrobianos para lograr una formulacion de dosis multiples usando ciclodextrinas beta para formas de dosificacion liquidas | |
| TW202333732A (zh) | 呼吸道刺激劑之非經腸調配物 | |
| EP4426308A1 (en) | Methods of treating respiratory depression modulated by a non-opioid agent | |
| AR125594A1 (es) | Moduladores alostéricos negativos novedosos de ciclopenta[c]pirrol de nr2b | |
| US20240238303A1 (en) | Large-conductance potassium channel modulators, compositions thereof, methods of manufacturing thereof, and methods of use thereof | |
| CN118829433A (zh) | 呼吸刺激剂肠胃外制剂 | |
| RU2010113937A (ru) | Производные 1-аминоалкилциклогексана для лечения и предупреждения потери слуха | |
| BR112013004265A2 (pt) | cloridrato, cristais de um dicloridrato, de um monocloridrato, e de um cloridrato, métodos para produzir um cloridrato, um cristal de um dicloridrato, e um cristal de um monocloridrato, medicamento, agente antitumor, e, composição farmacêutica |